KIORA PHARMACEUTICALS INC Quarterly Revenues in USD from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Kiora Pharmaceuticals Inc quarterly/annual Revenues history and growth rate from Q2 2017 to Q2 2024.
  • Kiora Pharmaceuticals Inc Revenues for the quarter ending June 30, 2024 was $20K.
  • Kiora Pharmaceuticals Inc annual Revenues for 2018 was $1.65M, a 306% increase from 2017.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $20K +$20K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $16M +$16M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q2 2023 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q2 2019 $3M $0 -$242K -100% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $3.24M $2.69M +$1.59M +145% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $1.65M $0 Oct 1, 2018 Dec 31, 2018 10-K 2019-03-01
Q3 2018 $315K +$240K +321% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $242K +$93.7K +63.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.1M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q3 2017 $74.7K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $148K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.